Strategies to prevent adverse outcomes following Clostridioides difficile infection in the elderly

Expert Rev Anti Infect Ther. 2020 Mar;18(3):203-217. doi: 10.1080/14787210.2020.1717950. Epub 2020 Jan 27.

Abstract

Introduction: Clostridioides difficile remains the most common cause of healthcare-associated infections in the US, and it disproportionately affects the elderly. Older patients are more susceptible and have a greater risk of adverse outcomes from C. difficile infection (CDI), despite advances in treatment and prevention.Areas covered: The epidemiology and pathogenesis of CDI, as well as risk factors in the aging host, will be reviewed. The importance of antimicrobial stewardship and infection prevention in order to avoid acquisition and transmission will be discussed, as well as strategies to prevent adverse outcomes and recurrent CDI, through optimization of CDI treatment s,election.Expert opinion: Appropriate CDI-prevention strategies to avoid adverse outcomes in this susceptible population involve antimicrobial stewardship and methods to prevent C. difficile transmission in healthcare settings. Management strategies to prevent adverse outcomes include initiation of supportive therapy and proper selection of CDI specific treatments. Many patients may also benefit from adjunctive therapies or additional procedures.

Keywords: Adverse outcomes; Clostridioides difficile; antimicrobial stewardship; elderly; infection prevention.

Publication types

  • Review

MeSH terms

  • Aged
  • Animals
  • Anti-Bacterial Agents / administration & dosage*
  • Antimicrobial Stewardship
  • Clostridioides difficile / isolation & purification
  • Clostridium Infections / drug therapy*
  • Clostridium Infections / epidemiology
  • Clostridium Infections / prevention & control
  • Cross Infection / drug therapy*
  • Cross Infection / epidemiology
  • Cross Infection / microbiology
  • Humans
  • Risk Factors

Substances

  • Anti-Bacterial Agents